Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Distribution and Viability of Peripheral Blood Mononuclear Cells from Imatinib-resistant Chronic Myeloid Leukemia Patients: an In Vitro Study

Indonesian Journal of Cancer Chemoprevention · Vol. 14 No. 1 (2023) · hlm. 22–32

DOI
10.14499/indonesianjcanchemoprev14iss1pp22-32
ISSN
2355-8989, 2088-0197
Terbit
2023-02-28
Penerbit
Indonesian Society for Cancer Chemoprevention
Bahasa
eng

Abstrak

The incidence of Chronic Myeloid Leukemia (CML) in the world is approximately 1.5 cases per 100,000 individuals. The level of resistance to CML treatment, imatinib in Indonesia is relatively high compared to Europe. Culturing CML cells can be used as a model for the determination of pathogenesis of CML, drug efficacy testing, and drug resistance testing. Studies using CML patients’ cells to be cultured in vitro and the methods used are rarely varied. This study aims to examine the distribution and viability of peripheral blood mononuclear cells from imatinib-resistant CML patients, expected to be a reference for mononuclear cell cultures from CML patients. This study was conducted in June-August 2019 using quantitative descriptive methods. The sample was mononuclear cells isolated from peripheral blood of three imatinib-resistant CML patients at the Hemato-Oncology Polyclinic of Hasan Sadikin Hospital, each of which was cultured in vitro using RPMI 1640 for 28 days. Distribution were seen using Giemsa staining, while viability was calculated using trypan blue. Data is processed using Microsoft Excel 2013 and Graphpad. Cell viability decreased during culture. Cell distribution had a different development pattern. Blast cells, eosinophils and basophils had presentation of between 0-5%. The percentage of lymphocyte changed between 11-31%. The percentage of neutrophil changed between 16-41%. The percentage of immature cells decreased, whereas the percentage of monocyte increased. In conclusion, cell viability decreases during the culture. Distribution of cells similar to the initial condition lasted until the 7th day and in the final phase it was only dominated by monocytes.Keywords: myeloid leukemia, chronic, cell culture, in vitro, peripheral blood mononuclear cell, cell viability.

Jaringan kolaborasi para penulis

40 penulis · 159 tautan kepenulisan bersama · 52 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Padjadjaran University
  • IPB University
  • Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo
  • Diponegoro University
  • Bandung Institute of Technology
  • Andalas University
  • Khairun University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Tenny PutriPadjadjaran University3
Erick KhristianPadjadjaran University1
Ratu SafitriPadjadjaran University1
Mohammad GhozaliPadjadjaran University1
Edhyana SahiratmadjaPadjadjaran University1
Dikdik KurniaPadjadjaran University1
Eveline YuniartiPadjadjaran University1
Nurul QomarillaPadjadjaran University1
Mieke Hermiawati SatariPadjadjaran University1
Fathul HudaPadjadjaran University1
Sarah SabrinaPadjadjaran University1
Resti Gradia DwiwinaPadjadjaran University1
Yuni Susanti PratiwiPadjadjaran University1
Putri HalleyanaPadjadjaran University1
Adrikni RahmanPadjadjaran University1
Fachreza Aryo DamaraPadjadjaran University1
Isna Nisrina HardaniPadjadjaran University1
Gita Widya PradiniPadjadjaran University1
Eko Fuji AriyantoPadjadjaran University1
Yosie AndrianiAfiliasi tidak diketahui1
Neviaty Putri ZamaniIPB University1
Syafrizayanti SyafrizayantiAndalas University1
Elfahmi ElfahmiBandung Institute of Technology1
Inna Puspa AyuIPB University1
Beginer SubhanIPB University1
Lalu M. Iqbal SaniIPB University1
Novriyandi HanifIPB University1
Nebuchadnezzar AkbarKhairun University1
Ni Kadek Dita CahyaniDiponegoro University1
Dondy ArafatIPB University1
Siti Zanuba AisyahIPB University1
Aditia R.R.Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo1
Andhika RachmanRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo1
Cosphiadi IrawanRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo1
Sukamto KoesnoeRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo1
Patricia Diana PrasetiyoDiponegoro University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://ijcc.chemoprev.org/index.php/ijcc/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Distribution and Viability of Peripheral Blood Mononuclear Cells from Imatinib-resistant Chronic Myeloid Leukemia Patients: an In Vitro Study</dc:title>
	<dc:creator>Ramadhanti, Julia</dc:creator>
	<dc:creator>Utami, Kharima Dwi</dc:creator>
	<dc:creator>Bashari, Muhammad Hasan</dc:creator>
	<dc:creator>Wijaya, Indra</dc:creator>
	<dc:description xml:lang="en-US">The incidence of Chronic Myeloid Leukemia (CML) in the world is approximately 1.5 cases per 100,000 individuals. The level of resistance to CML treatment, imatinib in Indonesia is relatively high compared to Europe. Culturing CML cells can be used as a model for the determination of pathogenesis of CML, drug efficacy testing, and drug resistance testing. Studies using CML patients’ cells to be cultured in vitro and the methods used are rarely varied. This study aims to examine the distribution and viability of peripheral blood mononuclear cells from imatinib-resistant CML patients, expected to be a reference for mononuclear cell cultures from CML patients. This study was conducted in June-August 2019 using quantitative descriptive methods. The sample was mononuclear cells isolated from peripheral blood of three imatinib-resistant CML patients at the Hemato-Oncology Polyclinic of Hasan Sadikin Hospital, each of which was cultured in vitro using RPMI 1640 for 28 days. Distribution were seen using Giemsa staining, while viability was calculated using trypan blue. Data is processed using Microsoft Excel 2013 and Graphpad. Cell viability decreased during culture. Cell distribution had a different development pattern. Blast cells, eosinophils and basophils had presentation of between 0-5%. The percentage of lymphocyte changed between 11-31%. The percentage of neutrophil changed between 16-41%. The percentage of immature cells decreased, whereas the percentage of monocyte increased. In conclusion, cell viability decreases during the culture. Distribution of cells similar to the initial condition lasted until the 7th day and in the final phase it was only dominated by monocytes.Keywords: myeloid leukemia, chronic, cell culture, in vitro, peripheral blood mononuclear cell, cell viability.</dc:description>
	<dc:publisher xml:lang="en-US">Indonesian Society for Cancer Chemoprevention</dc:publisher>
	<dc:contributor xml:lang="en-US"></dc:contributor>
	<dc:date>2023-02-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ijcc.chemoprev.org/index.php/ijcc/article/view/415</dc:identifier>
	<dc:identifier>10.14499/indonesianjcanchemoprev14iss1pp22-32</dc:identifier>
	<dc:source xml:lang="en-US">Indonesian Journal of Cancer Chemoprevention; Vol 14, No 1 (2023); 22-32</dc:source>
	<dc:source>2355-8989</dc:source>
	<dc:source>2088-0197</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ijcc.chemoprev.org/index.php/ijcc/article/view/415/274</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Indonesian Journal of Cancer Chemoprevention</dc:rights>
</oai_dc:dc>